Spelling suggestions: "subject:"transforming growth factors"" "subject:"ransforming growth factors""
31 |
The role of TGF-{221} signaling in the initiation of TNF-α expression in human PBMC derived macrophagesKam, Siu-kei, Christy., 甘笑琪. January 2006 (has links)
published_or_final_version / abstract / Surgery / Master / Master of Philosophy
|
32 |
Probing the molecular mechanisms of how polymorphisms in Cerberus-likeresult in low bone mineral densityLee, B. C., Bob., 李卜駿. January 2007 (has links)
published_or_final_version / Biochemistry / Master / Master of Philosophy
|
33 |
A role for transforming growth factor alpha and its receptor in human oesophageal cancerJones, Gregory Justin January 1993 (has links)
A dissertation submitted to the Faculty of Science, University of the
Witwatersrand, Johannesburg, in fulfilment of the requirements for the
degree of Master of Science. / A member of the epidermal growth factor (EGF) family; transforming
growth factor alpha (TGF-a) shares significant homology with EGF and
binds to the EGF receptor (EGF-R). Like EGF TGF-a plays important
roles in normal physiological processes; but, as its name signifies, it has
potent transforming ability; often associated with autocrine stimulatory
mechanisms. The purpose of this study is to investigate a possible role
for TGF-a and its receptor in certam human oesophageal squamous cell
carcinoma (SCC) cell lines - namely, WHCO-I, -3 and -5. The wellstudied
A431 epidermoid. carcinoma cell line was used throughout for
control purposes. (Abbreviation abstract) / Andrew Chakane 2018
|
34 |
Inhibition of cellular proliferation by retinoids and transforming growth factor-betas in bovine mammary cells correlates with increased connexin43 expressionWoodward, Terry L. January 1996 (has links)
No description available.
|
35 |
Biochemistry of ovine bone and morphogenetic proteins and receptorsMace, Peter, n/a January 2006 (has links)
The transforming growth factor (TGF)-β superfamily mediates a wide range of differentiation and developmental processes across many genera. GDF9 and BMP15 are expressed exclusively in the mammalian ovary and are the only TGF-β ligands that lack the conserved cysteine residue used for dimerisation. As a platform for studying the interactions between GDF9 and BMP15 and their receptors, BMPRII and BMPRIb, a variety of strategies were attempted to produce soluble and active proteins from recombinant systems. Both ligands and receptors showed a tendency to form insoluble aggregates when expressed in prokaryotic systems; however after extensive screening, quantities of biologically active GDF9 were produced using in vitro refolding. When expressed alone, either containing a histidine tag or as an untagged protein, the BMPRII ectodomain was deposited as insoluble inclusion bodies. This protein, subjected to in vitro refolding procedures, exhibited multiple species following anion exchange chromatography and size exclusion chromatography, as visualised on native PAGE. Separation of these species could be achieved using a MonoP matrix. One of these separated fractions, representing about 5% of the starting material, was amenable to crystallisation, and furthermore exhibited activity in a rat granulosa cell thymidine incorporation assay. Two different crystals forms of the extracellular domain of BMPRII were grown from the same protein batch under similar crystallisation conditions. Notably, the tetragonal form that grew more slowly possessed several disordered finger regions, while electron density for the entire molecule was clear in the orthorhombic form. The hydrophobic core of the ligand binding surface of BMPRII , as seen in both structures, resembles that of ActRII bound to BMP2. The A-loop of BMPRII, which is involved in ligand binding, lies in two different conformations in the two structures of BMPRII, mediated by a rearrangement in disulfide Cys94-Cys117. It is proposed here that the tetragonal form represents the ligand-bound receptor structure. Although the majority of the hydrophobic binding surface is shared with ActRII(b), it is likely that His87 and Tyr40 are unique residues that confer specificity in BMPRII ligand binding.
|
36 |
Regulation of 1,25D(3)-MARRS expression by TGFB1 in a rat intestinal epithelial cell lineRohe, Benjamin G. January 2006 (has links)
Thesis (M.S.)--University of Delaware, 2006. / Principal faculty advisor: Mary C. Farach-Carson, Dept. of Biological Sciences. Includes bibliographical references.
|
37 |
Studies in cranial suture biologyPremaraj, Sundaralingam. January 2006 (has links)
Thesis (Ph. D.)--Ohio State University, 2006. / Title from first page of PDF file. Includes bibliographical references (p. 137-153).
|
38 |
Effects of TGF-[beta] signalling components on MEF2 (myocyte-specific enhancer factor 2) transcriptional regulatory proteins and myogenesisQuinn, Zoë Anne. January 2000 (has links)
Thesis (Ph. D.)--York University, 2000. Graduate Programme in Biology. / Typescript. Includes bibliographical references (leaves 153-184). Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://wwwlib.umi.com/cr/yorku/fullcit?pNQ67888.
|
39 |
Smads in human trophoblast cells expression and roles in transforming growth factor-[beta]'s transcriptional activities /Wu, Dongning. January 2001 (has links)
Thesis (M. Sc.)--York University, 2001. / Typescript. Includes bibliographical references (leaves 69-89). Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://wwwlib.umi.com/cr/yorku/fullcit?pMQ67745.
|
40 |
Expression of transforming growth factors (TGF-alpha and TGF-beta 1) on postmortem skin wounds林詩敏, Lam, Sze-man, Joyce. January 2007 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
Page generated in 0.0717 seconds